AP NEWS

U.S. Pharmaceutical Preparation Market Report 2018 - Analysis and Forecast 2007-2025 - ResearchAndMarkets.com

November 8, 2018

DUBLIN--(BUSINESS WIRE)--Nov 8, 2018--The “U.S. Pharmaceutical Preparation Market Analysis and Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering.

The report provides on a detailed study of the U.S. pharmaceutical preparation market. It displays the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnover in the industry. In addition, the report contains insightful information about the industry, including industry life cycle, business locations, productivity, employment and many other crucial aspects. The Company Profiles section contains actual data on the leading players in the industry.

Report Coverage

Pharmaceutical preparations, affecting neoplasms, the endocrine system, and metabolic diseases, for human use Pharmaceutical preparations, acting on the central nervous system and the sense organs, for human use Pharmaceutical preparations, acting on the cardiovascular system, for human use Pharmaceutical preparations, acting on the respiratory system, for human use Pharmaceutical preparations, acting on the digestive or the genito-urinary systems, for human use Pharmaceutical preparations, acting on skin, for human use Pharmaceutical preparations, vitamin, nutrient, and hematinic preparations, for human use Pharmaceutical preparations, affecting parasitic and infective diseases, for human use (excluding diagnostics) Pharmaceutical preparations for veterinary use (including medicinal premixes and medicated pet care products

Key Topics Covered:

1. Introduction

2. Executive Summary

3. Market Overview

4. Most Promising Products

5. Most Promising Supplying Countries

6. Most Promising Overseas Markets

7. Production

8. Imports

9. Exports

10. Profiles Of Major Producers

Pfizer Inc. Merck & Co. Abbott Laboratories Abbvie Inc. Eli Lilly and Company Bristol-Myers Squibb Company Genentech Baxter International Allergan Biogen, Glaxosmithkline Celgene Corporation Hospira Alere Perrigo Company Mylan Inc. Regeneron Pharmaceuticals Novartis Corporation Alexion Pharmaceuticals Genzyme Corporation Zoetis Sanofi US Services Olympus Partners Valeant Pharmaceuticals International Merck Sharp & Dohme Corp. Glaxosmithkline Holdings (Americas) Wyeth Astrazeneca Pharmaceuticals Actavis Inc. Alcon Laboratories Holding Corporation Roche Holdings

For more information about this report visit https://www.researchandmarkets.com/research/2j6cf3/u_s?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181108005861/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Pharmaceuticals

KEYWORD: UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 11/08/2018 02:31 PM/DISC: 11/08/2018 02:30 PM

http://www.businesswire.com/news/home/20181108005861/en

AP RADIO
Update hourly